Julie Papanek Grant
CIK 1673237 · last filed 2023-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$205.28M
Companies
2
Total Filings
22
Lifetime Open-Market Net
-$19.77M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Director | 467,358 | $21.53 | $10.06M | -$26.77M | 19 | 2023-03-03 |
| PTGX | Director | 1,869,922 | $109.78 | $205.28M | $7.00M | 3 | 2017-05-26 |
Recent Filings · Page 3 of 3
22 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-09-15 | PTGX | Grant (A) | — | $0 | EDGAR |
| 2016-08-16 | PTGX | Mixed | +2,453,255 | $7.00M | EDGAR |
Showing 21–22 of 22
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.